Core throw a crowdfunding country in order to develop people’s relationship with the psychedelic industry.
The adventure studio subsidiary of a venture capital company Iter Investments aims to advance psychedelic-assisted therapy amid global mental health crises.
On behalf of Iter Investments, founder dustin robinson explained: “We launched and invested in Nucleus because my fund recognized that the fledgling psychedelic industry had many gaps that needed to be filled to help the industry move forward.
Logan Lenz, CEO of Nucleus that “it is important to us at Nucleus that everyone who wishes to have a stake in the world of psychedelic-assisted therapy has the opportunity to do so”.
The crowdfunding campaign will distribute equity in Nucleus to those who participate.
Addressing the newly launched campaign, Lenz said, “We believe providing the opportunity for anyone to make a real investment in Nucleus via crowdfunding is the best way to allow our audience to own a stake in Nucleus and share in all of its success.”
Why seize the crowdfunding opportunity?
The assignment the driving force behind Nucleus’ work is to be able to provide tools and opportunities to industry stakeholders, be they investors, potential patients, practitioners or professionals. The company intends to do this through its wholly owned asset portfoliocurrently holding a total of 12 brands, with more expected to join in the near future.
Nucleus has built these companies to bridging media, data and technology gaps within the industry. The content of the platforms ranges from offering up-to-date data to the ability to connect with ecosystem professionals (Neuly) and providing information on sector investments (psychedelic investing) to a marketing space for mental health practitioners (Psyrise), a directory of practitioners (psychedelic researcher), and a course offering psychedelic-assisted therapy (material academy).
To date, the Nucleus community has over 50,000 members, and the new crowdfunding campaign inviting investors to join will be open from October 26.